Healthtech Moving Beyond Hype: The Shift Towards Value & ROI in 2026 (2026)

The health tech industry is undergoing a significant transformation, and contrary to some beliefs, it's not hitting rock bottom. Instead, we're witnessing a shift from hype to tangible value.

After a challenging year in 2025, marked by a sharp contraction, health tech is now in a phase where funding decisions are driven by immediate returns on investment rather than long-term promises. This efficiency cycle is a game-changer.

The Israeli Health Tech Scene: A Story of Resilience and Adaptation

Despite a notable slowdown in funding and deal volume, Israeli health tech continues to thrive. In 2025, it recorded the highest number of deals across all sectors, surpassing even cyber and enterprise software. This achievement is a testament to the country's innovative spirit and its ability to adapt to changing market dynamics.

Shlomi Kofman, the VP and head of international collaborations at the Israel Innovation Authority, highlights the unique advantages of Israel's health tech ecosystem. With an unusually high concentration of medical innovation centers and healthcare technology companies, Israel is a hotbed for groundbreaking health tech ventures.

"The ability to collect and analyze data is a game-changer," Kofman emphasizes. "It enables us to build the next generation of health tech companies that push the boundaries of what's possible."

But here's where it gets controversial...

While the interest in Israeli health tech is global, with initiatives like the Horizon Europe funding program fostering international cooperation, some argue that this focus on efficiency and immediate returns could limit innovation.

Kofman, however, believes that these cooperation initiatives are crucial for Israel's long-term success, opening doors for pilot projects and preventing the country from being confined to a local market.

Recent outreach efforts, such as the IIA's visit to Silicon Valley, have reinforced this view. Despite an overall slowdown in deployment, investors and strategic players continue to show strong interest in Israeli health tech.

A Reset, Not a Downturn

Yariv Lotan, VP of product and data at Startup Nation Central, describes the current phase as a necessary reset rather than a downturn.

"We're in an efficiency cycle where startups must shift their focus from selling future potential to delivering immediate ROI. Hospitals are under financial strain, and cutting costs and administrative burdens in the short term is crucial. We might also see a wave of consolidation," Lotan predicts.

This shift has direct implications for product strategy. Solutions that promise long-term transformation without near-term financial or operational impact are facing challenges in raising capital, especially in hospital-facing segments.

However, Lotan emphasizes that the slowdown shouldn't be mistaken for a loss of technological potential, particularly in AI-driven healthcare.

"The funding dip is a reflection of investor caution, not technological exhaustion. We're far from reaching the 'bottom of the well.' It's a natural progression from hype to delivering real value."

The Future of Health Tech: Agentic AI and Operational Interventions

According to Lotan, the next phase of health tech innovation is all about moving beyond retrospective analytics. The focus is on operational systems that actively intervene in care delivery.

"The next wave is 'Agentic AI' - systems that triage patients and manage workflows in real-time. It's not just about analyzing data; it's about taking action. The market is vast, but the entry bar is higher. Investors now demand strong unit economics and tangible results, not just innovative algorithms."

In summary, the health tech market heading into 2026 is narrower but more disciplined. Capital is available, but it's reserved for companies that can demonstrate measurable impact, clear buyers, and credible paths to revenue in the near term.

So, what's your take on this shift in the health tech industry? Is it a necessary evolution or a potential limitation on innovation? Feel free to share your thoughts and opinions in the comments below!

Healthtech Moving Beyond Hype: The Shift Towards Value & ROI in 2026 (2026)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Tyson Zemlak

Last Updated:

Views: 6060

Rating: 4.2 / 5 (63 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Tyson Zemlak

Birthday: 1992-03-17

Address: Apt. 662 96191 Quigley Dam, Kubview, MA 42013

Phone: +441678032891

Job: Community-Services Orchestrator

Hobby: Coffee roasting, Calligraphy, Metalworking, Fashion, Vehicle restoration, Shopping, Photography

Introduction: My name is Tyson Zemlak, I am a excited, light, sparkling, super, open, fair, magnificent person who loves writing and wants to share my knowledge and understanding with you.